Enrollment Completed for Doublle Bio hUC-MSCs Phase I Low-Dose Group
The enrollment of the low-dose group in the Phase I clinical trial of Dabao Biological Human Umbilical Cord Mesenchymal Stem Cells has been completed
[Patient Recruitment] Clinical Recruitment for Stem Cell Treatment of Type 2 Diabetes
Phase I clinical study on the safety, tolerability, and preliminary efficacy of E10I stem cell therapy for type 2 diabetes
GuangZhou Doublle Biotech successfully passed the CNAS regular supervision and expans…
The Biological Testing Center of Guangzhou Doublle Biological Products Co., Ltd. has successfully passed the regular supervision review and testing capability expansion review conducted by the China National Accreditation Service for Conformity Assessment (CNAS)